Anti-PD-1 (Camrelizumab), Humanized Antibody
Catalogue number:
A2132-100
Supplier:
BioVision
Size:
100 µg _$$_
Product is available in:
N/A
Shipping is calculated in checkout
This product is no longer available to order.
Applications:
In vivo studies
Antibody Host:
CHO cells
Antibody Isotype:
Human IgG4
Antibody Type:
Monoclonal
Immunogen:
Camrelizumab
- Data sheet: View or download
Product Description:
Camrelizumab (AiRuiKa™) is a humanized monoclonal IgG4 anti-PD-1 monoclonal antibody developed by Jiangsu Hengrui Medicine Co. Ltd for the treatment of various solid and hematological malignancies. Upon administration, the antibody blocks the binding of PD-1 to its ligands PD-L1 and PD-L2. This inhibits PD-1 downstream signaling and restores normal immune function by activating cytotoxic T lymphocytes and T cell-mediated immune responses against cancer cells. Currently, Camrelizumab is being investigated for treatment of advanced hepatocellular carcinoma (HCC), non-small cell lung cancer (NSCLC) and Hodgkin lymphoma
Storage Temperature:
4°C